136 related articles for article (PubMed ID: 11216931)
1. Herpes zoster and HIV-1 infection in a rural Ugandan cohort.
Morgan D; Mahe C; Malamba S; Okongo M; Mayanja B; Whitworth J
AIDS; 2001 Jan; 15(2):223-9. PubMed ID: 11216931
[TBL] [Abstract][Full Text] [Related]
2. Herpes zoster and the stage and prognosis of HIV-1 infection.
McNulty A; Li Y; Radtke U; Kaldor J; Rohrsheim R; Cooper DA; Donovan B
Genitourin Med; 1997 Dec; 73(6):467-70. PubMed ID: 9582462
[TBL] [Abstract][Full Text] [Related]
3. Herpes zoster and progression to AIDS in a cohort of individuals who seroconverted to human immunodeficiency virus. Italian HIV Seroconversion Study.
Alliegro MB; Dorrucci M; Pezzotti P; Rezza G; Sinicco A; Barbanera M; Castelli F; Tarantini G; Petrucci A
Clin Infect Dis; 1996 Nov; 23(5):990-5. PubMed ID: 8922791
[TBL] [Abstract][Full Text] [Related]
4. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection.
Veenstra J; Krol A; van Praag RM; Frissen PH; Schellekens PT; Lange JM; Coutinho RA; van der Meer JT
AIDS; 1995 Oct; 9(10):1153-8. PubMed ID: 8519451
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?
Morgan D; Mahe C; Mayanja B; Okongo JM; Lubega R; Whitworth JA
AIDS; 2002 Mar; 16(4):597-603. PubMed ID: 11873003
[TBL] [Abstract][Full Text] [Related]
6. Predictive values of prurigo nodularis and herpes zoster for HIV infection and immunosuppression requiring HAART in French Guiana.
Magand F; Nacher M; Cazorla C; Cambazard F; Marie DS; Couppié P
Trans R Soc Trop Med Hyg; 2011 Jul; 105(7):401-4. PubMed ID: 21621233
[TBL] [Abstract][Full Text] [Related]
7. Herpes zoster and human immunodeficiency virus infection.
Buchbinder SP; Katz MH; Hessol NA; Liu JY; O'Malley PM; Underwood R; Holmberg SD
J Infect Dis; 1992 Nov; 166(5):1153-6. PubMed ID: 1308664
[TBL] [Abstract][Full Text] [Related]
8. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Moore RD; Chaisson RE
Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
[TBL] [Abstract][Full Text] [Related]
9. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort.
Kaleebu P; Ross A; Morgan D; Yirrell D; Oram J; Rutebemberwa A; Lyagoba F; Hamilton L; Biryahwaho B; Whitworth J
AIDS; 2001 Feb; 15(3):293-9. PubMed ID: 11273208
[TBL] [Abstract][Full Text] [Related]
10. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
11. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study.
Morgan D; Mahe C; Mayanja B; Whitworth JA
BMJ; 2002 Jan; 324(7331):193-6. PubMed ID: 11809639
[TBL] [Abstract][Full Text] [Related]
12. An HIV-1 natural history cohort and survival times in rural Uganda.
Morgan D; Malamba SS; Maude GH; Okongo MJ; Wagner HU; Mulder DW; Whitworth JA
AIDS; 1997 Apr; 11(5):633-40. PubMed ID: 9108945
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster as an indicator of HIV infection in Africa.
Dehne KL; Dhlakama DG; Richter C; Mawadza M; McClean D; Huss R
Trop Doct; 1992 Apr; 22(2):68-70. PubMed ID: 1604717
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 disease progression and mortality before the introduction of highly active antiretroviral therapy in rural Uganda.
Van der Paal L; Shafer LA; Todd J; Mayanja BN; Whitworth JA; Grosskurth H
AIDS; 2007 Nov; 21 Suppl 6():S21-9. PubMed ID: 18032935
[TBL] [Abstract][Full Text] [Related]
15. Incidence of HIV-1 infection in a rural region of Uganda.
Wawer MJ; Sewankambo NK; Berkley S; Serwadda D; Musgrave SD; Gray RH; Musagara M; Stallings RY; Konde-Lule JK
BMJ; 1994 Jan; 308(6922):171-3. PubMed ID: 8312767
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster as the initial presentation of human immunodeficiency virus type 1 infection in Kenya.
Tyndall MW; Nasio J; Agoki E; Malisa W; Ronald AR; Ndinya-Achola JO; Plummer FA
Clin Infect Dis; 1995 Oct; 21(4):1035-7. PubMed ID: 8645797
[TBL] [Abstract][Full Text] [Related]
17. Impact of CCR5 Delta32/+ deletion on herpes zoster among HIV-1-infected homosexual men.
Krol A; Lensen R; Veenstra J; Prins M; Schuitemaker H; Coutinho RA
Eur J Epidemiol; 2006; 21(6):469-73. PubMed ID: 16703416
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 disease progression and AIDS-defining disorders in rural Uganda.
Morgan D; Maude GH; Malamba SS; Okongo MJ; Wagner HU; Mulder DW; Whitworth JA
Lancet; 1997 Jul; 350(9073):245-50. PubMed ID: 9242801
[TBL] [Abstract][Full Text] [Related]
19. Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in Uganda.
Iwuji CC; Mayanja BN; Weiss HA; Atuhumuza E; Hughes P; Maher D; Grosskurth H
HIV Med; 2011 Oct; 12(9):553-61. PubMed ID: 21535347
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis.
Jansen K; Haastert B; Michalik C; Guignard A; Esser S; Dupke S; Plettenberg A; Skaletz-Rorowski A; Brockmeyer NH
BMC Infect Dis; 2013 Aug; 13():372. PubMed ID: 23937603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
